Already a member? Sign in
Levemir® is a brand name intermediate to long-acting insulin detemir used in the treatment of type 1 diabetes mellitus (insulin dependent); type 2 diabetes mellitus (noninsulin dependent) to control hyperglycemia. It is available in a FlexPen® prefilled syringe.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Diabetes Type 2 | 12 | 0 | |||||
| Diabetes Type 1 | 6 | 0 | |||||
| Elevated blood sugar (hyperglycemia) | 4 | 1 |
|
||||
| Diabetic Neuropathy | 2 | 1 |
|
||||
| Balance problems | 1 | 1 |
|
||||
| Cystic Fibrosis Related Diabetes | 1 | 0 |
See all 26 patients currently taking Levemir FlexPen
Mouse over the table for more information
Frequently reported dosages based on patients currently taking Levemir FlexPen. See all 27 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 1 | ||
| Other | 1 |
Adherence
Taking treatment as prescribed
Adherence of Levemir FlexPen
Always |
1 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Levemir FlexPen
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
0 | 0% |
|
Not at all |
1 | 100% |
|
Cost
Paid out of pocket
Cost of Levemir FlexPen
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
1 | 100% |
|
Report created on May 28, 2012.